Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Growth

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 7.7642.48-15.611.9932.11

What is the latest Core EBITDA Growth ratio of AJANTA PHARMA ?

The latest Core EBITDA Growth ratio of AJANTA PHARMA is 7.76 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20257.76
Mar202442.48
Mar2023-15.61
Mar20221.99
Mar202132.11

How is Core EBITDA Growth of AJANTA PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 7.76
-81.73
Mar2024 42.48
Positive
Mar2023 -15.61
Negative
Mar2022 1.99
-93.80
Mar2021 32.11 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Growth ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹39,849.3 Cr -2.2% 14.8% 25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,195.0 Cr 0.9% 12.7% 8.2% Stock Analytics
DIVIS LABORATORIES ₹182,993.0 Cr -0.4% 9.7% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,926.0 Cr 0.5% 5.8% 36.5% Stock Analytics
CIPLA ₹113,052.0 Cr -2.7% 13.9% -6.2% Stock Analytics
DR REDDYS LABORATORIES ₹110,333.0 Cr 1.5% 7.3% 8% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-2.2%

14.8%

25%

SENSEX

1%

-4.1%

-7.4%


You may also like the below Video Courses